Costa Matthew L, Achten Juul, Griffin James, Petrou Stavros, Pallister Ian, Lamb Sarah E, Parsons Nick R
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Department of Trauma and Orthopaedic Surgery, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.
JAMA. 2017 Nov 14;318(18):1767-1776. doi: 10.1001/jama.2017.16429.
The best treatment for fractures of the distal tibia remains controversial. Most such fractures require surgical fixation but outcomes are unpredictable and complications are common.
To assess disability, quality of life, and complications in patients with displaced tibial fracture treated with intramedullary nail fixation vs locking plate fixation.
DESIGN, SETTING, AND PARTICIPANTS: A multicenter randomized trial recruiting 321 patients 16 years or older with an acute, displaced, extra-articular fracture of the distal tibia from April 2013 through April 2016 with final follow-up in February 2017. Exclusion criteria included open fractures, fractures involving the ankle joint, contraindication to nailing, or inability to complete questionnaires.
Intramedullary nail fixation (nail group; n = 161), a metal rod inserted into the hollow center of the tibia, vs locking plate fixation (plate group; n = 160), a plate attached to the surface of the tibia with fixed-angle screws.
Disability Rating Index (DRI; score range, 0 [no disability] to 100 [complete disability]) at 6 months was the primary outcome measure, with a minimal clinically important difference of 8 points. DRI measurement was also collected at 3 and 12 months. Secondary outcomes were the Olerud-Molander Ankle Score (OMAS), quality of life, and complications (such as infection and further surgery).
Among 321 randomized patients (mean age, 45 years [SD, 16.2]; men, 197 [61%]; had experienced traumatic injury after a fall, 223 [69%]), 258 completed the study. There was no statistically significant difference in the DRI score at 6 months between groups (mean score, 29.8 in the nail group vs 33.8 in the plate group; adjusted difference, 4.0 [95% CI, -1.0 to 9.0], P = .11). There was a statistically significant difference in the DRI score at 3 months in favor of nail fixation (mean score, 44.2 in the nail group and 52.6 in the plate group; adjusted difference, 8.8 [95% CI, 4.3 to 13.2], P < .001), but not at 12 months (mean score, 23.1 in the nail group and 24.0 in the plate group; adjusted difference, 1.9 [95% CI, -3.2 to 6.9], P = .47). Secondary outcomes showed the same pattern, including a statistically significant difference in mean OMAS at 3 and 6 months in favor of nail fixation. There were no statistically significant differences in complications, including the number of postoperative infections (9% in the nail group vs 13% in the plate group). Further surgery was more common in the plate group at 12 months (8% in nail group vs 12% in plate group).
Among patients 16 years or older with an acute, displaced, extra-articular fracture of the distal tibia, neither nail fixation nor locking plate fixation resulted in superior disability status at 6 months. Other factors may need to be considered in deciding the optimal approach.
clinicaltrials.gov Identifier: ISRCTN99771224.
胫骨干骺端骨折的最佳治疗方法仍存在争议。大多数此类骨折需要手术固定,但结果不可预测且并发症很常见。
评估髓内钉固定与锁定钢板固定治疗移位性胫骨骨折患者的残疾情况、生活质量和并发症。
设计、地点和参与者:一项多中心随机试验,从2013年4月至2016年4月招募321名16岁及以上的急性、移位、关节外胫骨干骺端骨折患者,最终随访时间为2017年2月。排除标准包括开放性骨折、累及踝关节的骨折、钉固定的禁忌症或无法完成问卷。
髓内钉固定(髓内钉组;n = 161),即将一根金属棒插入胫骨的中空中心,与锁定钢板固定(钢板组;n = 160),即用固定角度螺钉将钢板附着于胫骨表面。
6个月时的残疾评定指数(DRI;评分范围为0[无残疾]至100[完全残疾])是主要结局指标,最小临床重要差异为8分。在3个月和12个月时也收集DRI测量值。次要结局包括奥勒鲁德 - 莫兰德踝关节评分(OMAS)、生活质量和并发症(如感染和再次手术)。
在321名随机分组的患者中(平均年龄45岁[标准差16.2];男性197名[61%];跌倒后发生创伤性损伤223名[69%]),258名完成了研究。两组在6个月时的DRI评分无统计学显著差异(髓内钉组平均评分为29.8,钢板组为33.8;校正差异为4.0[95%置信区间,-1.0至9.0],P = 0.11)。在第3个月时,DRI评分在髓内钉固定方面有统计学显著差异(髓内钉组平均评分为44.2,钢板组为52.6;校正差异为- .8[95%置信区间,4.3至13.2],P < 0.001),但在12个月时无差异(髓内钉组平均评分为23.1,钢板组为24.0;校正差异为1.9[95%置信区间,-3.2至6.9],P = 0.47)。次要结局显示出相同的模式,包括在3个月和6个月时平均OMAS在髓内钉固定方面有统计学显著差异。并发症方面无统计学显著差异,包括术后感染数量(髓内钉组为9%,钢板组为13%)。在12个月时,钢板组再次手术更为常见(髓内钉组为8%,钢板组为12%)。
在16岁及以上的急性、移位、关节外胫骨干骺端骨折患者中,髓内钉固定和锁定钢板固定在6个月时均未导致更优的残疾状况。在决定最佳治疗方法时可能需要考虑其他因素。
clinicaltrials.gov标识符:ISRCTN99771224 。